Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 119,642 | 122,598 | 108,164 | 115,284 | 124,948 |
| Income taxes - deferred | N/A | N/A | -2,319 | 4,307 | 30,423 |
| Accounts receivable | N/A | N/A | -29,608 | 67,252 | 554 |
| Accounts payable and accrued liabilities | N/A | N/A | 165,523 | N/A | N/A |
| Other Working Capital | 46,636 | -79,650 | 91,909 | 17,058 | -23,827 |
| Other Operating Activity | 233,815 | 203,029 | 65,343 | 202,759 | 243,343 |
| Operating Cash Flow | $400,093 | $245,977 | $399,012 | $406,660 | $375,441 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -131,069 | -114,008 | -161,679 | -125,401 | -124,358 |
| Net Acquisitions | -9,112 | -55,442 | -8,949 | -12,061 | -56,615 |
| Purchase Of Investment | N/A | -55,442 | N/A | N/A | N/A |
| Other Investing Activity | 169,451 | -114,008 | 0 | 0 | 0 |
| Investing Cash Flow | $29,270 | $-338,902 | $-170,627 | $-137,462 | $-180,973 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -66,120 | 44,215 | 29,501 |
| Debt Issued | N/A | N/A | 1,992,214 | -2,615 | 324,688 |
| Debt Repayment | N/A | N/A | -1,811,673 | -463,145 | -407,814 |
| Dividend Paid | N/A | N/A | 6,160 | 3,011 | N/A |
| Other Financing Activity | -210,764 | -192,096 | -301,570 | 93,113 | -48,408 |
| Financing Cash Flow | $-210,764 | $-192,096 | $-180,990 | $-325,421 | $-102,033 |
| Exchange Rate Effect | -8,216 | -3,904 | 1,104 | 8,360 | -10,745 |
| Beginning Cash Position | 417,771 | 537,245 | 482,123 | 535,054 | 434,953 |
| End Cash Position | 450,313 | 417,771 | 520,255 | 482,123 | 535,054 |
| Net Cash Flow | $49,148 | $-115,570 | $47,394 | $-56,224 | $92,435 |
| Free Cash Flow | |||||
| Operating Cash Flow | 400,093 | 245,977 | 399,012 | 406,660 | 375,441 |
| Capital Expenditure | -27,653 | -228,798 | -160,194 | -131,301 | -125,866 |
| Free Cash Flow | 372,440 | 17,179 | 238,818 | 275,358 | 249,575 |